Click here to load reader
Upload
market-research-reports-inc
View
156
Download
1
Embed Size (px)
Citation preview
www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: January 31, 2014
Number of Pages: 303
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 9,995
Price For Site License: USD 19,990
Price For Global User License: USD 29,985
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
PharmaPoint: Prophylactic Hepatitis B Virus VaccinesGlobal Drug Forecast and Market Analysis to 2022,Hepatitis B, which is caused by the hepatitis B virus (HBV),is characterized by acute or chronic inflammation of theliver. Researchers and healthcare experts have estimatedthat roughly two billion people are infected with HBVworldwide, with roughly 600,000 people dying each yearfrom HBV-related liver diseases.
Prophylactic Hepatitis B Virus Vaccines Global sales toreach over $1.1 billion by 2022.
www.MarketResearchReports.com
Key Findings
Country-specific immunization recommendations heavilyinfluence HBV vaccine uptake in the pediatric and adultsegments of the marketplace.
The potential impact of Dynavax Technologies’ Heplisav on themarketplace will be determined by its level of uptake in at-riskadults targeted for vaccination.
Major players will leverage their R&D, manufacturing, anddistribution networks to maintain their stakes in the market.
Government endorsements of new and existing vaccines, inparticular pediatric combination vaccines and novel adultvaccines, are anticipated to dramatically influence marketgrowth.
www.MarketResearchReports.com
Scope:
Overview of hepatitis B virus (HBV), including etiology, generalsymptoms from infection, and country-specific immunizationrecommendations and vaccination coverage data.
Annualized HBV vaccine market revenue, annual cost ofvaccination and treatment usage pattern data from 2012 andforecast for ten years to 2022.
Key topics covered include strategic competitor assessment,market characterization, unmet needs, clinical trial mapping andimplications for the HBV vaccine market.
Pipeline analysis: comprehensive data split across differentphases and emerging trends, specifically Dynavax Technologies’Heplisav and Sanofi Pasteur MSD’s Hexyon.
Analysis of the current and future market competition in theglobal HBV vaccine market. Insightful review of the key industryand governmental drivers, restraints and challenges. Each trendis independently researched to provide qualitative analysis of itsimplications.
www.MarketResearchReports.com
Reason to Buy:
Develop and design your in-licensing and out-licensing strategiesthrough a review of pipeline products and technologies, and byidentifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping anddriving the HBV vaccine market.
Drive revenues by understanding the key trends, innovative productsand technologies, market segments, and companies likely to impact theglobal HBV vaccine market in the future.
Formulate effective sales and marketing strategies by understandingthe competitive landscape and by analyzing the performance of variouscompetitors.
Identify emerging players with potentially strong product portfoliosand create effective counter-strategies to gain a competitive advantage.
Track drug sales in the global HBV vaccine market from 2012-2022.
Organize your sales and marketing efforts by identifying the marketcategories and segments that present maximum opportunities forconsolidations, investments and strategic partnerships.
www.MarketResearchReports.com
Report Coverage
1. Table of Contents
2. Introduction
3. Disease Overview
4. Vaccination Recommendations and Coverage Rates
5. Competitive Assessment
6. Opportunity and Unmet Need
7. Pipeline Assessment
8. Current and Future Players
9. Market Outlook
10.Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Company Coverage:
1. GSK
2. Merck
3. Sanofi
4. Kaketsuken
5. Dynavax Technologies
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research:
Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Zde
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : [email protected]
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)